vs
FIRST MID BANCSHARES, INC.（FMBH）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
FIRST MID BANCSHARES, INC.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.2倍（$88.2M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 3.4%），FIRST MID BANCSHARES, INC.自由现金流更多（$124.0M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 5.0%）
First Mid Bancshares Inc.是一家总部位于美国的区域性金融服务控股公司，提供全品类零售与商业银行产品、财富管理、保险解决方案及农业融资服务，主要服务伊利诺伊、密苏里、印第安纳等美国中西部州的个人、中小企业及农业客户。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
FMBH vs PBYI — 直观对比
营收规模更大
FMBH
是对方的1.2倍
$75.5M
营收增速更快
PBYI
高出24.3%
3.4%
自由现金流更多
FMBH
多$109.6M
$14.4M
两年增速更快
PBYI
近两年复合增速
5.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $88.2M | $75.5M |
| 净利润 | $23.7M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 34.0% | 22.7% |
| 净利率 | 26.8% | — |
| 营收同比 | 3.4% | 27.7% |
| 净利润同比 | 23.5% | — |
| 每股收益（稀释后） | $0.98 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FMBHPBYI
| Q4 25 | $88.2M | $75.5M | ||
| Q3 25 | $89.3M | $54.5M | ||
| Q2 25 | $87.5M | $52.4M | ||
| Q1 25 | $84.3M | $46.0M | ||
| Q4 24 | $85.3M | $59.1M | ||
| Q3 24 | $80.6M | $80.5M | ||
| Q2 24 | $79.2M | $47.1M | ||
| Q1 24 | $79.9M | $43.8M |
净利润FMBHPBYI
| Q4 25 | $23.7M | — | ||
| Q3 25 | $22.5M | $8.8M | ||
| Q2 25 | $23.4M | $5.9M | ||
| Q1 25 | $22.2M | $3.0M | ||
| Q4 24 | $19.2M | — | ||
| Q3 24 | $19.5M | $20.3M | ||
| Q2 24 | $19.7M | $-4.5M | ||
| Q1 24 | $20.5M | $-4.8M |
毛利率FMBHPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率FMBHPBYI
| Q4 25 | 34.0% | 22.7% | ||
| Q3 25 | 32.2% | 17.6% | ||
| Q2 25 | 34.4% | 12.7% | ||
| Q1 25 | 33.4% | 8.7% | ||
| Q4 24 | 29.7% | 22.6% | ||
| Q3 24 | 31.5% | 27.4% | ||
| Q2 24 | 33.7% | -4.6% | ||
| Q1 24 | 33.7% | -5.3% |
净利率FMBHPBYI
| Q4 25 | 26.8% | — | ||
| Q3 25 | 25.2% | 16.2% | ||
| Q2 25 | 26.8% | 11.2% | ||
| Q1 25 | 26.3% | 6.5% | ||
| Q4 24 | 22.5% | — | ||
| Q3 24 | 24.2% | 25.2% | ||
| Q2 24 | 24.9% | -9.6% | ||
| Q1 24 | 25.6% | -11.0% |
每股收益（稀释后）FMBHPBYI
| Q4 25 | $0.98 | $0.26 | ||
| Q3 25 | $0.94 | $0.17 | ||
| Q2 25 | $0.98 | $0.12 | ||
| Q1 25 | $0.93 | $0.06 | ||
| Q4 24 | $0.81 | $0.40 | ||
| Q3 24 | $0.81 | $0.41 | ||
| Q2 24 | $0.82 | $-0.09 | ||
| Q1 24 | $0.86 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | $354.5M | $22.7M |
| 股东权益账面价值 | $958.7M | $130.3M |
| 总资产 | $8.0B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.37× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资FMBHPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务FMBHPBYI
| Q4 25 | $354.5M | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益FMBHPBYI
| Q4 25 | $958.7M | $130.3M | ||
| Q3 25 | $932.2M | $115.3M | ||
| Q2 25 | $894.1M | $104.7M | ||
| Q1 25 | $870.9M | $97.1M | ||
| Q4 24 | $846.4M | $92.1M | ||
| Q3 24 | $858.5M | $71.1M | ||
| Q2 24 | $813.6M | $48.5M | ||
| Q1 24 | $798.0M | $51.0M |
总资产FMBHPBYI
| Q4 25 | $8.0B | $216.3M | ||
| Q3 25 | $7.8B | $202.9M | ||
| Q2 25 | $7.7B | $194.9M | ||
| Q1 25 | $7.6B | $196.2M | ||
| Q4 24 | $7.5B | $213.3M | ||
| Q3 24 | $7.6B | $220.7M | ||
| Q2 24 | $7.6B | $205.0M | ||
| Q1 24 | $7.7B | $214.1M |
负债/权益比FMBHPBYI
| Q4 25 | 0.37× | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $130.9M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $124.0M | $14.4M |
| 自由现金流率自由现金流/营收 | 140.6% | 19.1% |
| 资本支出强度资本支出/营收 | 7.8% | 0.0% |
| 现金转化率经营现金流/净利润 | 5.53× | — |
| 过去12个月自由现金流最近4个季度 | $207.9M | $41.7M |
8季度趋势，按日历期对齐
经营现金流FMBHPBYI
| Q4 25 | $130.9M | $14.4M | ||
| Q3 25 | $33.0M | $9.7M | ||
| Q2 25 | $7.7M | $14.1M | ||
| Q1 25 | $47.9M | $3.6M | ||
| Q4 24 | $124.4M | $15.6M | ||
| Q3 24 | $33.1M | $11.0M | ||
| Q2 24 | $24.0M | $1.0M | ||
| Q1 24 | $29.0M | $11.2M |
自由现金流FMBHPBYI
| Q4 25 | $124.0M | $14.4M | ||
| Q3 25 | $31.9M | $9.7M | ||
| Q2 25 | $6.0M | $14.1M | ||
| Q1 25 | $46.0M | $3.6M | ||
| Q4 24 | $119.5M | $15.6M | ||
| Q3 24 | $32.0M | $11.0M | ||
| Q2 24 | $22.9M | $1.0M | ||
| Q1 24 | $27.6M | — |
自由现金流率FMBHPBYI
| Q4 25 | 140.6% | 19.1% | ||
| Q3 25 | 35.8% | 17.7% | ||
| Q2 25 | 6.8% | 26.8% | ||
| Q1 25 | 54.5% | 7.7% | ||
| Q4 24 | 140.0% | 26.4% | ||
| Q3 24 | 39.7% | 13.7% | ||
| Q2 24 | 28.9% | 2.1% | ||
| Q1 24 | 34.5% | — |
资本支出强度FMBHPBYI
| Q4 25 | 7.8% | 0.0% | ||
| Q3 25 | 1.2% | 0.0% | ||
| Q2 25 | 2.0% | 0.0% | ||
| Q1 25 | 2.3% | 0.1% | ||
| Q4 24 | 5.8% | 0.0% | ||
| Q3 24 | 1.4% | 0.0% | ||
| Q2 24 | 1.4% | 0.0% | ||
| Q1 24 | 1.9% | 0.0% |
现金转化率FMBHPBYI
| Q4 25 | 5.53× | — | ||
| Q3 25 | 1.47× | 1.10× | ||
| Q2 25 | 0.33× | 2.41× | ||
| Q1 25 | 2.16× | 1.21× | ||
| Q4 24 | 6.49× | — | ||
| Q3 24 | 1.70× | 0.54× | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 1.42× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
